tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Ownership - Who Owns Chimeric Therapeutics Ltd.?

1 Followers

Chimeric Therapeutics Ltd. (CHM) Ownership Overview

14.97%0.00%0.00%85.03%
14.97% Insiders
0.00% Other Institutional Investors
85.03% Public Companies and
Individual Investors
The ownership structure of Chimeric Therapeutics Ltd. (AU:CHM) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 14.97% is owned by Insiders and 85.03% is owned by Public Companies and Individual Investors.
The ownership structure of Chimeric Therapeutics Ltd. (AU:CHM) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 14.97% is owned by Insiders and 85.03% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 14, 2023
Philips Hains
Non Executive,director
BoughtAU$100000
Aug 28, 2023
Paul Hopper
Chairman & Founder, >10% Owner
BoughtAU$30000
Jul 17, 2023
Jennifer Chow
Chief Executive Officer & Managing Director
BoughtAU$5000
Jul 17, 2023
Paul Hopper
Chairman & Founder, >10% Owner
BoughtAU$600000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
94,994,574Insider11.15%2,564,853
18,094,527Insider2.12%488,552
10,326,028Insider1.21%278,803
2,087,756Insider0.25%56,369
1,739,130Insider0.20%46,957
154,900Insider0.02%4,182
141,368Insider0.02%3,817

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Chimeric Therapeutics Ltd. (AU:CHM)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 14.97% is held by insiders, and 85.03% is held by retail investors.
    What percentage of Chimeric Therapeutics Ltd. (AU:CHM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.00% of Chimeric Therapeutics Ltd. (AU:CHM) stock is held by institutional investors.
      What percentage of Chimeric Therapeutics Ltd. (AU:CHM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 85.03% of Chimeric Therapeutics Ltd. (AU:CHM) stock is held by retail investors.
        Who owns the most shares of Chimeric Therapeutics Ltd. (AU:CHM)?
        Paul Hopper owns the most shares of Chimeric Therapeutics Ltd. (AU:CHM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis